Senior executives

Dr Masoud Khayyami

CEO
Shares: 13 346 933*

Ph.D. in Chemistry at Lund University. Solid experience from research, medicine, medtech and the biotechnology sectors. Extensive entrepreneurial experience (Prolight Diagnostics AB, Lumito AB and Gasporox AB) and expert knowledge in applied medicine, microbiology and biotech, specifically with regard to the development of various types of biomolecules for commercial use and research in biological applications. Board member both in medtech companies and other companies. Committed to SpectraCure since 2010.

Masoud Khayyami, as a shareholder and CEO, is neither independent of the owners nor the Company.

*Ownership privately and via companies.

Johannes Swartling

CTO
Shares: 79 300

Johannes Swartling has a Ph.D. in physics from Lund University (2002). He has worked at SpectraCure since 2006 and is responsible for research and development at the company. He has experience in development of medical devices, clinical trials, and quality and regulatory work including risk management. Before joining SpectraCure AB, he held post-doctoral research positions at Politecnico di Milano, Italy, and at Cambridge University, UK. His research has been on applications of laser technology and spectroscopy in biology and medicine, His research has been on applications of laser technology and spectroscopy in biology and medicine, and he is the author of some 30 original peer-reviewed research papers.

Johannes Swartling is independent of the owners.

Henrik Ljung

CFO
Shares: 2 000

Henrik Ljung has an MBA and has several years of experience as the CFO of Cerdo Bankpartner AB, Acconeer AB, Ballingslöv AB, Sardus AB, and Malmöhus Invest AB, among others.